Abstract
Amyloid peptide (Aβ) oligomers are considered one of the primary causal factors for the synaptic loss characteristic of Alzheimer's disease (AD) (Karran and De Strooper, 2016). However, Aβ is generated in normal brains and accumulates at synaptic sites, which raises the question whether Aβ plays a physiological role in synapses. This unresolved issue is especially relevant in view of the recent AD therapeutic strategies aimed at blocking or reducing Aβ production. Here, we justify the use of the Drosophila adult neuromuscular junction (NMJ) as a model to address this question, describe our recent results that indicate that Aβ regulates synapse dynamics, and suggest future approaches to understand Aβ synaptic function.